Skip to main content
Fig. 5 | Breast Cancer Research

Fig. 5

From: Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study

Fig. 5

Recurrence-free survival (RFS) and breast cancer-specific survival (BCSS) in patients with different change rates of CD8+ tumor-infiltrating lymphocyte (TIL), FOXP3+ TIL, and CD8/FOXP3 ratio. Estimated Kaplan-Meier curves of RFS (a) and BCSS (b) in patients with high or low change rates of CD8+ TIL before and after neoadjuvant chemotherapy, those of RFS (c) and BCSS (d) in patients with high or low change rates of FOXP3+ TIL, and those of RFS (e) and BCSS (f) in patients with high or low change rates of CD8/FOXP3 ratio

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us